Prognostic factores and combined use of Tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients.

I this study we describe the clinical course and analyze the prognostic factors associated with a higher risk of mortality in a cohort of elderly patientes. We assess the efficacy of inmunosupressive treatments in this population.